360 related articles for article (PubMed ID: 23783459)
1. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
Debnath T; Kim DH; Lim BO
Molecules; 2013 Jun; 18(6):7253-70. PubMed ID: 23783459
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory activity of traditional Chinese medicinal herbs.
Pan MH; Chiou YS; Tsai ML; Ho CT
J Tradit Complement Med; 2011 Oct; 1(1):8-24. PubMed ID: 24716101
[TBL] [Abstract][Full Text] [Related]
3. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
[TBL] [Abstract][Full Text] [Related]
4. Curcumin has bright prospects for the treatment of inflammatory bowel disease.
Hanai H; Sugimoto K
Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Effects of Fargesin on Chemically Induced Inflammatory Bowel Disease in Mice.
Yue B; Ren YJ; Zhang JJ; Luo XP; Yu ZL; Ren GY; Sun AN; Deng C; Wang ZT; Dou W
Molecules; 2018 Jun; 23(6):. PubMed ID: 29880739
[TBL] [Abstract][Full Text] [Related]
6. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.
Mijan MA; Lim BO
World J Gastroenterol; 2018 Jul; 24(25):2673-2685. PubMed ID: 29991873
[TBL] [Abstract][Full Text] [Related]
7. Review of natural products actions on cytokines in inflammatory bowel disease.
Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
[TBL] [Abstract][Full Text] [Related]
8. Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease?
Dijkstra G; Moshage H; Jansen PL
Scand J Gastroenterol Suppl; 2002; (236):37-41. PubMed ID: 12408502
[TBL] [Abstract][Full Text] [Related]
9. Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure-activity relationships.
Chen J; Gao Y; Zhang Y; Wang M
Food Funct; 2024 Jun; 15(11):5680-5702. PubMed ID: 38738935
[TBL] [Abstract][Full Text] [Related]
10. Suppression of MAPKs/NF-κB Activation Induces Intestinal Anti-Inflammatory Action of Ginsenoside Rf in HT-29 and RAW264.7 Cells.
Ahn S; Siddiqi MH; Aceituno VC; Simu SY; Yang DC
Immunol Invest; 2016 Jul; 45(5):439-49. PubMed ID: 27224660
[TBL] [Abstract][Full Text] [Related]
11. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
Tambuwala MM
Inflamm Bowel Dis; 2016 Mar; 22(3):719-23. PubMed ID: 26717321
[TBL] [Abstract][Full Text] [Related]
12. The application of natural product-delivering micro/nano systems in the treatment of inflammatory bowel disease.
Zhou Y; Feng X; Xu H; Guo J; Yang C; Kong L; Zhang Z
J Mater Chem B; 2023 Jan; 11(2):244-260. PubMed ID: 36512384
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.
Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y
Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095
[TBL] [Abstract][Full Text] [Related]
14. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.
Li B; Wang Y; Jiang X; Du H; Shi Y; Xiu M; Liu Y; He J
Biomed Pharmacother; 2023 Aug; 164():114950. PubMed ID: 37263167
[TBL] [Abstract][Full Text] [Related]
15. Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors.
Moss AC; Brinks V; Carpenter JF
Aliment Pharmacol Ther; 2013 Nov; 38(10):1188-97. PubMed ID: 24118102
[TBL] [Abstract][Full Text] [Related]
16. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways.
Kamalian A; Sohrabi Asl M; Dolatshahi M; Afshari K; Shamshiri S; Momeni Roudsari N; Momtaz S; Rahimi R; Abdollahi M; Abdolghaffari AH
World J Gastroenterol; 2020 Jun; 26(24):3365-3400. PubMed ID: 32655263
[TBL] [Abstract][Full Text] [Related]
17. Discovery of small-molecule candidates against inflammatory bowel disease.
Bai R; Jie X; Yao C; Xie Y
Eur J Med Chem; 2020 Jan; 185():111805. PubMed ID: 31703817
[TBL] [Abstract][Full Text] [Related]
18.
He W; Li Y; Liu M; Yu H; Chen Q; Chen Y; Ruan J; Ding Z; Zhang Y; Wang T
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301267
[TBL] [Abstract][Full Text] [Related]
19. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S; Angelucci E
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
